Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals

$0.580 (0%)

High $0.59	Low $0.57	Trades 36	Turnover $59,341	Volume 102,948
30 June 2023 at 3:56pm

Market Cap (19-Sep) $42,430,680 (621st)	Close (30-Jun) $0.58 0 (0%)	Volume (30-Jun) 102,948	Shortsold (3-Jul) 1,500 (0.00%) (620th)
52w High $0.155	52w Low $0.135	P/E 128.21	EPS -0.05

Short Interest

ASIC data, 3 Jul 2024

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

620th

of 710 shorted ASX stocks

Peak Short

9.59%

Jun 2012

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	NXS NXS Ann: Director Retirement
	1 (current) 2 3
	NXS NXS Ann: Market Update
	NXS NXS Ann: Appointment of new Managing Director and CEO
	NXS NXS Ann: 2023 AGM - Voting Results
	NXS NXS Ann: AGM Chair & Managing Director Addresses
	NXS NXS Ann: Quarterly Activity Report 31 March 2023 - Addendum
	NXS NXS Ann: Corporate Governance Statement and Appendix 4G
	NXS NXS Ann: 2023 AGM Notice of Meeting
	NXS NXS Ann: 2022 Annual Report
	NXS NXS Ann: Investor Presentation - Q1 2023
	NXS NXS Ann: Quarterly Activity Report - 31 March 2023
	NXS NXS Ann: Appendix 4C - 31 March 2023
	NXS NXS Ann: Notification of date of 2023 AGM
	NXS NXS Ann: Ceasing to be a substantial holder
	NXS NXS Ann: FY22 Investor Presentation
	NXS NXS Ann: Next Science FY22 Results and FY23 Outlook
	NXS NXS Ann: Appendix 4E / FY22 Financial Statements
	NXS NXS Ann: Full Year Results Investor Briefing
	NXS NXS Ann: Cleansing notice
	NXS NXS Ann: Notification regarding unquoted securities - NXS
	NXS NXS Ann: General Meeting - Voting Results
	NXS NXS Ann: Proposed issue of securities - NXS
	NXS NXS Ann: Cancel - Proposed issue of securities - NXS
	NXS NXS Ann: Proposed issue of securities - NXS
	NXS NXS Ann: Investor Presentation - Q4 2022
	NXS NXS Ann: Appendix 4C - 31 December 2022
	NXS NXS Ann: Quarterly Activity Report - 31 December 2022
	NXS NXS Ann: Notice of General Meeting
	NXS NXS Ann: Next Science secures A$10M convertible notes due 2024
	NXS NXS Ann: Change in substantial holding
	NXS NXS Ann: Investor Presentation - Q3 2022
	NXS NXS Ann: Investor Webinar
	NXS NXS Ann: Quarterly Activity Report - 30 September 2022
	NXS NXS Ann: Appendix 4C - 30 September 2022
	NXS NXS Ann: Next Science US Medicare accreditation signals growth
	NXS NXS Ann: Trading Halt
	NXS NXS Ann: Pause in Trading
	NXS NXS Ann: Next Science's XPERIENCE product cleared for sale in Canada
	NXS NXS Ann: Half Year Results Investor Presentation
	NXS NXS Ann: Half Year Report & Appendix 4D
	NXS NXS Ann: Half Year Results Investor Briefing
	NXS NXS Ann: Investor Presentation - Q2 2022
	NXS NXS Ann: Quarterly Activity Report - 30 June 2022
	NXS NXS Ann: Appendix 4C - 30 June 2022
	NXS NXS Ann: Change in substantial holding
	NXS NXS Ann: Cleansing notice
	NXS NXS Ann: Application for quotation of securities - NXS
	NXS NXS Ann: 2022 AGM - Voting Results
	NXS NXS Ann: AGM Chair & Managing Director Addresses
	NXS NXS Ann: Next Science to strengthen senior leadership presence in US

Similar Companies

Ansell

ANN

Anteris Technologies Ltd

AVR

Medigard

MGZ

Nanosonics

NAN

Osteopore

OSX

PolyNovo

PNV

SDI

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.15	322,774	0.00 (0.00%)
12-Sep	$0.15	16,656	0.00 (0.00%)
11-Sep	$0.15	21,171	+0.00 (1.72%)
05-Sep	$0.15	30,368	0.00 (0.00%)
04-Sep	$0.15	715,906	0.00 (0.00%)
03-Sep	$0.15	206,354	0.00 (0.00%)
29-Aug	$0.15	54,648	0.00 (0.00%)
28-Aug	$0.15	31,929	0.00 (1.69%)
22-Aug	$0.15	825,106	+0.00 (1.72%)
21-Aug	$0.15	171,743	0.00 (0.00%)
15-Aug	$0.15	1,595	0.00 (0.00%)
14-Aug	$0.15	161,432	+0.00 (3.57%)
07-Aug	$0.14	230,003	0.00 (0.00%)
31-Jul	$0.14	461,648	0.00 (1.75%)
30-Jul	$0.14	1,557,393	+0.00 (1.79%)
4 up, 2 down, and 9 flat days

Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Next Science Health Care Biotech Healthcare New Zealand North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals